The first-quarter earnings season is heating up—both in tempo and the numbers themselves.

When the rollback was announced shortly after Trump took action against DEI programs in the federal government by executive ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...

With 1,320 rental apartments and a host of amenities, 25 Water Street is the country’s largest office-to-residential ...

Cantor Fitzgerald initiated coverage on Pfizer, giving a neutral rating and a $24 target price. Despite recent analyst ...

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political ...

Goldman Sachs shareholders voted to approve pay packages, including hefty retention bonuses, for top executives CEO David ...

Intangible assets are nonphysical resources that generate economic and strategic value, such as patents, trademarks, customer ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Pfizer shares inched up 0.4% on Friday, riding a surge in trading volume that was 33% above average—call it a micro-win. Wall ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...